Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2009
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen
Jason A Dubovsky, Douglas G McNeel, John J Powers, et al.
Blood
|
September 27, 2014
IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells
Shuai Dong, Daphne Guinn, Jason A Dubovsky, et al.
Leukemia & Lymphoma
|
January 29, 2011
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
John J Powers, Jason A Dubovsky, P K Epling-Burnette, et al.
Leukemia Research
|
September 25, 2010
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers
Jason A Dubovsky, Daniel Wang, John J Powers, et al.
Blood Advances
|
April 20, 2018
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma
Anita Kumar, Santosha Vardhana, Alison J Moskowitz, et al.
Blood
|
September 7, 2013
Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing
Jason A Dubovsky, Danielle L Chappell, Bonnie K Harrington, et al.
The Journal of Biological Chemistry
|
January 17, 2015
Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694
Yiming Zhong, Shuai Dong, Ethan Strattan, et al.
Blood
|
May 15, 2015
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Ta-Ming Liu, Jennifer A Woyach, Yiming Zhong, et al.
Journal of Proteomics
|
January 18, 2016
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers
Sean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Blood
|
December 7, 2013
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)
Jennifer A Woyach, Engin Bojnik, Amy S Ruppert, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2009
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen
Jason A Dubovsky, Douglas G McNeel, John J Powers, et al.
Blood
|
September 27, 2014
IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells
Shuai Dong, Daphne Guinn, Jason A Dubovsky, et al.
Leukemia & Lymphoma
|
January 29, 2011
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
John J Powers, Jason A Dubovsky, P K Epling-Burnette, et al.
Leukemia Research
|
September 25, 2010
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers
Jason A Dubovsky, Daniel Wang, John J Powers, et al.
Blood Advances
|
April 20, 2018
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma
Anita Kumar, Santosha Vardhana, Alison J Moskowitz, et al.
Blood
|
September 7, 2013
Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing
Jason A Dubovsky, Danielle L Chappell, Bonnie K Harrington, et al.
The Journal of Biological Chemistry
|
January 17, 2015
Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694
Yiming Zhong, Shuai Dong, Ethan Strattan, et al.
Blood
|
May 15, 2015
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Ta-Ming Liu, Jennifer A Woyach, Yiming Zhong, et al.
Journal of Proteomics
|
January 18, 2016
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers
Sean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Blood
|
December 7, 2013
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)
Jennifer A Woyach, Engin Bojnik, Amy S Ruppert, et al.
Page
of 3